Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Global cardiac ablation devices market • Cardiac ablation catheters market PART 07: Market segmentation by procedures • Atrial fibrillation ablation • Supraventricular tachycardia ablation • Ventricular tachycardia ablation PART 08: Market segmentation by end-user • Hospitals and clinics • ASCs PART 09: Geographical segmentation • Cardiac ablation market in Americas • Cardiac ablation market in EMEA • Cardiac ablation market in APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 12: Market trends • Transforming marketing and sales strategies for cardiac ablation • Emergence of digital cath labs in hospitals • Integration of robotic cardiac catheter system and hybrid operating room equipment PART 13: Vendor landscape • Competitive landscape PART 14: Key vendor analysis • Boston Scientific • Medtronic • St. Jude Medical • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Global cardiac ablation market overview 2016 Exhibit 02: Global cardiac ablation market 2016-2021 ($ billions) Exhibit 03: Five forces analysis Exhibit 04: Global cardiac ablation market by product 2016 and 2021 ($ billions) Exhibit 05: Buying criteria of cardiac ablation products 2016 and 2021 Exhibit 06: Market overview: Global cardiac ablation devices market Exhibit 07: Global cardiac ablation devices market 2016-2021 ($ billions) Exhibit 08: Market overview: Cardiac ablation catheters market Exhibit 09: Global cardiac ablation catheters market 2016-2021 ($ billions) Exhibit 10: Global cardiac ablation market by procedures in 2016 Exhibit 11: Global cardiac ablation market by end-user in 2016 Exhibit 12: Global cardiac ablation market by geography 2016 and 2021 ($ billions) Exhibit 13: An overview of cardiac diseases in US Exhibit 14: Market overview: Cardiac ablation market in Americas Exhibit 15: Cardiac ablation market in Americas 2016-2021 ($ billions) Exhibit 16: Cardiac ablation market in Americas: Market analysis by country Exhibit 17: Market overview: Cardiac ablation market in US Exhibit 18: Impact of accountable care organizations (ACO) and ACA on cardiac ablation Exhibit 19: Market overview: Cardiac ablation market in Europe Exhibit 20: Cardiac ablation market in EMEA 2016-2021 ($ billions) Exhibit 21: Cardiac ablation market in EMEA: Market analysis by country Exhibit 22: Market overview: Cardiac ablation market in UK Exhibit 23: Market overview: Cardiac ablation market in APAC Exhibit 24: Cardiac ablation market in APAC 2016-2021 ($ billions) Exhibit 25: Cardiac ablation market in APAC: Market analysis by country Exhibit 26: Market overview: Cardiac ablation market in South Korea Exhibit 27: Increasing number of CVDs (hypertension) versus number of Medicare providers in US 2011-2013 Exhibit 28: Clinical studies for cardiac ablation: Companies and CROs Exhibit 29: Impact of drivers Exhibit 30: Cost of cardiac ablation products Exhibit 31: Research studies: Complications associated with cardiac ablation Exhibit 32: Product recalls 2014-2015 Exhibit 33: Impact of challenges Exhibit 34: Marketing and sales strategies by large and small companies Exhibit 35: Competitive structure analysis of global cardiac ablation market 2016 Exhibit 36: Competitive landscape of global cardiac ablation market 2016 Exhibit 37: Global cardiac ablation market: Market penetration of companies 2016 Exhibit 38: Strategies of large and small companies in global cardiac ablation market Exhibit 39: Boston Scientific: Strength assessment Exhibit 40: Boston Scientific: Strategy assessment Exhibit 41: Boston Scientific: Opportunity assessment Exhibit 42: Medtronic: Strength assessment Exhibit 43: Medtronic: Strategy assessment Exhibit 44: Medtronic: Opportunity assessment Exhibit 45: St. Jude Medical: Strength assessment Exhibit 46: St. Jude Medical: Strategy assessment Exhibit 47: St. Jude Medical: Opportunity assessment Exhibit 48: Other prominent vendors in global cardiac ablation market

Boston Scientific, Medtronic, St. Jude Medical, AblaCor, Advanced Cardiac Therapeutics, and AngioDynamics.